Global Overview of Cannabis Regulation in New Zealand and Europe

Global Overview of Cannabis Regulation in New Zealand and Europe The passage provides a factual summary of cannabis law changes across several jurisdictions but contains no specific allegations, financial flows, or connections to high‑profile individuals or agencies. It offers limited investigative value beyond general policy context. Key insights: New Zealand lifted restrictions on CBD prescriptions in September 2017 and considered domestic medical cannabis production in December 2017.; EU lacks a unified cannabis framework; individual countries have varied medical cannabis regimes.; Italy, Croatia, Germany, and Poland have enacted medical cannabis laws with import‑license mechanisms for foreign producers.